In this episode, we focus on the personal journey of Sheila Gujrathi, a physician turned biotech builder whose career spans medicine, big pharma, rapid IPOs, and billion dollar exits. We explore what it takes to raise biotech across cycles, from early clinical development to public markets, and how Sheila navigated building companies while operating in environments where she was rarely the default.
Surani speaks with Sheila about growing up as the child of Indian immigrant physicians, making unconventional career decisions, and learning to balance patients, capital, and leadership under pressure. They discuss her time at Genentech and Bristol Myers Squibb, her role in scaling Receptos through IPO and a $7.2 billion acquisition, the founding and listing of Gossamer Bio, and how those experiences shaped her perspective on leadership and led to her writing The Mirror Effect.
00:00: Introduction
01:45: Growing up as the child of Indian immigrant physicians and early expectations around medicine
04:50: Loss, identity, and the year in India that helped shape a personal North Star going into Medical School
10:30: Leaving clinical medicine and stepping into consulting and industry
15:45: Joining Receptos, building from the ground up, and the road to IPO and acquisition
22:50: Founding Gossamer Bio, raising private capital, and going public in just over a year
30:10: Reflection, writing The Mirror Effect, and building pathways for the next generation
For more on Sheila's Book, click here
For any comments, questions or feedback you can connect directly with Surani Fernando on LinkedIn or email: raisingbiotech@gmail.com
Title music composed by: Yrii Semchyshyn (Coma Media)